USPTO Validates Multilyte's Basic Microarray IP Portfolio | GenomeWeb
NEW YORK (GenomeWeb News) — The US Patent and Trademark Office has issued an ex parte re-examination certificate to Multilyte for its basic microarray patent portfolio, validating the IP, Multilyte said this week.
The move, which strengthens Multilyte’s IP portfolio as it “endeavor[s] to license” them, was requested by the company and by Affymetrix ex parte.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.